Nedocromil

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nedocromil
Nedocromil.svg
Systematic (IUPAC) name
9-ethyl-4,6-dioxo-10-propyl-6,9-dihydro-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid
Clinical data
Trade names Alocril
AHFS/Drugs.com monograph
MedlinePlus a601243
Legal status
Routes Inhalation and eye drops
Pharmacokinetic data
Protein binding 89%
Metabolism not metabolized
Half-life ~3.3 hours
Excretion excreted unchanged
Identifiers
CAS number 69049-73-6 YesY
ATC code R01AC07 R03BC03, S01GX04
PubChem CID 50294
DrugBank DB00716
ChemSpider 45608 YesY
UNII 0B535E0BN0 YesY
KEGG D05129 YesY
ChEBI CHEBI:7492 YesY
ChEMBL CHEMBL746 YesY
Chemical data
Formula C19H17NO7 
Mol. mass 371.341 g/mol
 YesY (what is this?)  (verify)

Nedocromil sodium is a medication considered as mast cell stabilizer which act to prevent wheezing, shortness of breath, and other breathing problems caused by asthma. It is administered by an inhaler under the brand name Tilade (although its effects in this form are far less than those in albuterol or other well-known inhaler medications) and as an eye drop under the brand name Alocril.[1][2] Liquid preparations are available in the UK under the name Rapitil for use for allergic eye reactions.[3]

Nedocromil is classified as a cromone. Nedocromil acts as a mast cell stabilizer, inhibits the degranulation of mast cells, prevents release of histamine and tryptase, so preventing the synthesis of prostaglandins and leukotrienes. US Production of inhaled nedocromil ceased in April 2008.[4]

References[edit]

Media related to Nedocromil at Wikimedia Commons